Skip to Main Content

Paper Details

Intrathecal trastuzumab in the management of HER2+ breast leptomeningeal disease: a single institution experience.
Breast Cancer Res Treat
27
2018
Author NameAffiliation
Nam D TranH. Lee Moffitt Cancer Center and Research Institute
  • 1 - 1

Datasets

Release 1.2